Astec Lifesciences trying to close above mid channel resistnace.Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. Its products include Tebuconazole, Propiconazole, Hexaconazole, and Difenoconazole.
Astec LifeSciences Ltd CMP is 1287.05. The positive aspects of the company are Growth in Net Profit with increasing Profit Margin (QoQ) and Company with Zero Promoter Pledge. The Negative aspects of the company are MFs decreased their shareholding last quarter, Degrowth in Revenue and Profit and Annual net profit declining for last 2 years.
Entry can be taken after closing above 1309. Targets in the stock will be 1356 and 1406. The long-term target in the stock will be 1469. Stop loss in the stock should be maintained at Closing below 1247.
The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
